Beyond the ER-mediated pathway, another pathway linking oxysterols to breast cancer progression includes the liver X receptor (LXR), primarily expressed in liver, intestine, adipocytes, and macrophages with various functions including the regulation of the cholesterol metabolism. This evidence concerns the gene ESR1 and breast cancer.